Survival analysis showed that TERTp mutation was a predictor of better prognosis in IDH‐mutant grade 2 gliomas, while poor OS was associated with all Grade 4 gliomas and all IDH‐wildtype histology grade 2 or 3 gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.